Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Liabilities ₹1,026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr

What is the latest Total Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Liabilities ratio of NATH BIOGENES (INDIA) is ₹1,026 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹1,026 Cr
Mar2024₹880 Cr
Mar2023₹793 Cr
Mar2022₹739 Cr
Mar2013₹157 Cr

How is Total Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹1,026 Cr
16.58
Mar2024 ₹880 Cr
11.03
Mar2023 ₹793 Cr
7.21
Mar2022 ₹739 Cr
369.87
Mar2013 ₹157 Cr -

Compare Total Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹330.6 Cr -1.2% -4% -22.7% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,564.5 Cr -2.2% -6.1% -30.2% Stock Analytics
KAVERI SEED COMPANY ₹5,945.6 Cr 0.3% 4.3% 7.5% Stock Analytics
VENKYS (INDIA) ₹2,078.0 Cr -0.2% -3.4% -35.4% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,527.5 Cr 7.8% 8.8% -28.5% Stock Analytics
INDO US BIOTECH ₹299.4 Cr -0.8% -6.8% -41.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-1.2%

-4%

-22.7%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses